The Nuclear Medicine or Radiopharmaceuticals Market in 2023 is US$ 5.5 billion, and is expected to reach US$ 13.16 billion by 2031 at a CAGR of 11.50%.

FutureWise Research published a report that analyzes Nuclear Medicine or Radiopharmaceuticals Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.

Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This Nuclear Medicine or Radiopharmaceuticals research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.

Request a Sample Report @ Request for Nuclear Medicine or Radiopharmaceuticals Market Sample

Nuclear Medicine or Radiopharmaceuticals Market Segmentation:
By Type
• Diagnostic Nuclear Medicine
• Spect Radiopharmaceuticals
• Tc-99m
• Tl-201
• Ga-67
• I-123
• Other Spect Isotopes
• Pet Radiopharmaceuticals
• F-18
• Ru-82
• Other Pet Isotopes
• Therapeutic Nuclear Medicine
• Alpha Emitters
• Ra-223
• Beta Emitters
• I-131
• Y-90
• Sm-153
• Re-186
• Lu-177
• Other Beta Emitters
• Brachytherapy Isotopes
• I-125
• Ir-192
• Pd-103
• Cs-131
• Other Brachytherapy Isotopes
By Application
• Diagnostic Applications
• Spect Applications
• Cardiology
• Lymphoma
• Neurology
• Thyroid
• Other Spect Applications
• Pet Applications
• Oncology
• Cardiology
• Neurology
• Other Pet Applications
• Therapeutic Applications
• Thyroid
• Bone Metastasis
• Lymphoma
• Endocrine Tumors
• Other Therapeutic Applications
By Procedural Volume
• Diagnostic Procedures
• Spect Radiopharmaceuticals
• Pet Radiopharmaceuticals
• Therapeutic Procedures
• Beta Emitters
• Alpha Emitters
• Brachytherapy Isotopes
By Region
• Europe
• North America
• Asia Pacific
• Rest of the World
Major players included in the Nuclear Medicine Or Radiopharmaceuticals Market:
• Cardinal Health Inc.
• Lantheus Medical Imaging Inc.,
• GE Healthcare,
• Eczacibasi-Monrol Nuclear Products,
• IBA Molecular Imaging,
• Bayer Healthcare, Nordion Inc,
• Bracco Imaging S.p.A,
• Advanced Accelerator Applications S.A.

Please visit full report of the Nuclear Medicine or Radiopharmaceuticals market @ Visit Nuclear Medicine or Radiopharmaceuticals Market
Competitive Landscape:
• Tier one players - market players with a significant share of the market
• Tier two players
• Players with rapid growth
• New Entries

FutureWise Key Takeaways:
• Prospects for growth
• Analysis of SWOT
• Key trends
• Key Data-points affecting market growth

Objectives of the Study:
• To provide report with an in-depth analysis of the Nuclear Medicine or Radiopharmaceuticals Market By Type, By Application, By Procedural Volume, and By Region
• To offer data-points and comprehensive data on factors affecting the market (Opportunities, drivers, and industry-specific restraints)
• Analysis and forecasting of micro-markets, as well as the scope of the market.
• To predict the size and share, market forecast, in key regions — North America, Europe, Asia Pacific, and rest of the world
• To record and evaluate competition -mergers and expansions, product launches, and technological advancements within the market

Flexible Delivery Model:
• With our flexible delivery model, you will be able to suggest changes within the scope/table of content based on your requirement.
• Customization services are included with the purchase of any license type of report.
• Customization requests can be sent directly to: [email protected]

FutureWise Research:
Contact Person: Vinay T.
Email: [email protected]
Contact Number: UK: +44 1416289353 | US: +1 3477094931
Website: www.futurewiseresearch.com